Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood added to Amazon, Kratos Defense, and Tempus AI on Wednesday, with Amazon highlighted for accelerating AWS growth, major AI-related cloud deals, and a UBS price target of $333 implying about 22% upside. Kratos and Tempus both beat expectations and raised revenue guidance, but each stock is down sharply this year—Kratos about 25% and Tempus about 20%—keeping the article focused on pullback buying rather than a clear fundamental inflection.

Analysis

AMZN is the cleanest second-order winner here because the market keeps underestimating how sticky AI infrastructure spend becomes once large customers embed workloads. The key nuance is that every multiyear AWS commitment improves forward visibility and compresses the odds of a near-term growth air pocket, which should support both multiple expansion and lower earnings volatility over the next 2-4 quarters. The real competitive threat is not just Azure or GCP; it is that smaller cloud budgets get crowded out as hyperscalers prioritize AI clusters, reinforcing winner-take-most dynamics in enterprise infrastructure.

SNOW’s deal structure is also important: its announced spending on AWS is effectively a demand signal for Amazon’s capacity layer, but it can pressure AWS economics if customers negotiate harder on price in exchange for volume. That creates a subtle margin-vs-growth debate for AMZN, but near term the market tends to reward revenue acceleration more than incremental margin dilution. By contrast, UBS-style price target upgrades matter less than the visible backlog compounding; this is a positioning story where systematic and growth funds likely keep chasing strength over the next few weeks.

KTOS and TEM look like classic post-earnings digestion names where fundamentals are better than tape, but expectations were still too high. For KTOS, defense demand is real, but the market wants proof that revenue conversion is scaling into durable operating leverage; until then, every guide-up but-quarter-down setup becomes a multiple reset rather than a rerate. TEM faces an even harder burden because healthcare AI is being priced as a platform story while revenue growth is slowing; that usually works only if there is a clear inflection in gross margin or commercial expansion, neither of which is obvious yet.

The contrarian setup is that Wood is likely buying optionality where the market is punishing timing, not thesis. That is attractive in AMZN, where scale and backlog reduce downside, but much less so in KTOS and TEM unless the next 1-2 quarters show margin inflection. The better expression is to own the quality compounder and fade the weakest execution names until relative strength confirms the turn.

Key Decisions for Investors

• Long AMZN into the next 2-6 weeks on pullbacks; preferred over SNOW because AWS backlog visibility plus AI capex leverage should keep estimate revisions positive. Risk/reward: favorable 2:1 if market continues rewarding infrastructure beneficiaries.
• Pair trade: long AMZN / short KTOS over the next 1-3 months. Thesis: both are in favored themes, but AMZN has durable cash flow and rerating support while KTOS still lacks proof of operating leverage. Use KTOS as the funding leg until margins inflect.
• Avoid initiating fresh long TEM until the next earnings cycle; if already long, consider reducing into strength and waiting for revenue reacceleration confirmation. Risk is a prolonged de-rating if growth keeps decelerating.
• For tactical exposure, buy AMZN call spreads 1-3 months out rather than stock if positioning is crowded. This captures upside toward a higher valuation band while limiting risk if AI capex enthusiasm stalls.
• Watch SNOW as a sentiment barometer for AWS demand rather than a primary long here; if SNOW continues to post large AWS commitments, it supports the AMZN bull case over the next quarter.